Spine devices, recalls and endovascular stents on FDA's fall meeting lineup

FDA's fall meeting lineup includes a roster that could impact a broad swath of the medtech industry, with sessions on evidence for spinal devices, how recalls are communicated, the safety of endovascular stents and artificial intelligence technology.